Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Raymond C. Wadlow, MD

Advertisement

Articles by Raymond C. Wadlow, MD

Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy

ByKhaled W. Kabbara, MD,Timothy Cannon, MD,Arthur Winer, MD,Raymond C. Wadlow, MD
August 19th 2022

Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.

Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer

ByMarwan Al-Hajeili, MD,Anthony F. Shields, MD, PhD,Jimmy J. Hwang, MD,Raymond C. Wadlow, MD,John L. Marshall, MD
April 15th 2017

Recent improvements in our understanding of the biology of colorectal cancer have led to the identification of several important prognostic and predictive markers of disease-associated risk and treatment response for the individual patient.

Advertisement

Latest Updated Articles

  • Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy
    Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy

    August 19th 2022

  • Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer
    Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer

    April 15th 2017



Advertisement
Advertisement

Trending on CancerNetwork

1

Setting Up an HDR Brachytherapy Program Amid a National Decline

2

Zamto-Cel Improves EFS vs R-GemOx in Transplant-Ineligible R/R LBCL

3

CD38-Targeted Immuno-PET Helps Detect Active Multiple Myeloma

4

Biomarker Sequencing, PD-L1 Status, and FLOT Dosing in Gastroesophageal Cancer

5

16-Fraction PMRT With IMN Irradiation Noninferior in High-Risk Breast Cancer

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us